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Abstract Volume homeostasis of the cochlear endolymph
depends on radial and longitudinal endolymph movements
(LEMs). LEMs measured in vivo have been exclusively rec-
ognized under physiologically challenging conditions, such as
experimentally induced alterations of perilymph osmolarity or
endolymph volume. The regulatory mechanisms that adjust
LEMs to the physiological requirements of endolymph vol-
ume homeostasis remain unknown. Here, we describe the for-
mation of an aquaporin (AQP)-based Bwater shunt^ during the
postnatal development of the mouse cochlea and its regulation
by different triggers. The final complementary expression pat-
tern of AQP5 (apical membrane) and AQP4 (basolateral mem-
brane) in outer sulcus cells (OSCs) of the cochlear apex is ac-
quired at the onset of hearing function (postnatal day (p)8–p12).
In vitro, hyperosmolar perfusion of the perilymphatic fluid
spaces or the administration of themuscarinic agonist pilocarpine
in cochlear explants (p14) induced the translocation of AQP5
channel proteins into the apical membranes of OSCs. AQP5
membrane translocation was blocked by the muscarinic antago-
nist atropine. The muscarinic M3 acetylcholine (ACh) receptor
(M3R) was identified in murine OSCs via mRNA expression,
immunolabeling, and in vitro binding studies using an M3R-
specific fluorescent ligand. Finally, the water shunt elements
AQP4, AQP5, and M3R were also demonstrated in OSCs of
the human cochlea. The regulation of the AQP4/AQP5 water
shunt in OSCs of the cochlear apex provides a molecular basis
for regulated endolymphatic volume homeostasis. Moreover, its
dysregulation or disruption may have pathophysiologic implica-
tions for clinical conditions related to endolymphatic hydrops,
such as Ménière’s disease.
Keywords Aquaporin . Cochlea .Water permeability .
Muscarinic . Pilocarpine .Ménière’s disease
Introduction
Volume regulation of the cochlear fluids, including the endo-
lymph and perilymph, is crucial for cochlear function and the
transduction of sound. Based on electric current measure-
ments [91] and the dispersal of tracer substances [2, 4, 22,
23, 45, 72–74] or ionic volume markers [76], two main ho-
meostatic mechanisms of inner ear fluid regulation have been
proposed, i.e., Bradial endolymph movements^ (REMs) [67]
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and Blongitudinal endolymph movements^ (LEMs) [27].
REMs occur locally across the cochlear duct epithelium by
endolymphatic ion secretion across the stria vascularis and
endolymphatic ion resorption by the sensory hair cells within
the organ of Corti [91] and other non-sensory epithelial cells
within the cochlear duct [58, 62]. REMs presumably consti-
tute the predominant homeostatic mechanism under normal
conditions. LEMs, in contrast, have been measured exclusive-
ly under experimentally induced pathophysiologic conditions,
such as disturbed perilymph osmolarity [76] or endolymph
volume [75]. In particular, LEMs within the scala media were
directed apically (baso-apical fluid flow) when the perilymph
osmolarity in the scalae vestibuli and tympani was increased
(400 mOsm/L [76]) or when the endolymph volume in the
scala media was reduced [75]. LEMs in the scala media were
directed basally (apico-basal fluid flow) when the osmolarity
of the perilymph was decreased compared with that of the
endolymph [76] or when the volume of the endolymph was
increased by artificial endolymph injections into the scala me-
dia [75]. Thus, bidirectional LEMs may correct endolymph
volume disturbances or osmotic imbalances under physiolog-
ically challenging conditions when REMs are insufficient to
maintain endolymph homeostasis [75, 76]. The molecular
mechanisms in the inner ear epithelium that trigger and regu-
late LEMs are, however, largely unknown. These molecular
mechanisms are of particular pathophysiological interest be-
cause their disturbances and the consecutive stagnation of
LEMs have been implicated in the generation of endolym-
phatic hydrops in Ménière’s disease [27, 52].
We previously described a Bwater shunt^ between the
perilymphatic and endolymphatic fluid spaces in the cochlear
apex of various mammalian species, including rats, mice, gerbils
[33], guinea pigs [21, 33], and humans [reviewed in 19, 20, 33].
This water shunt is established by the membranous localization
of two molecular water channel (aquaporin, AQP) subtypes in
the basolateral (AQP4) and apical (AQP5) membrane domains
of outer sulcus cells (OSCs), which reside at the perilymph–
endolymph barrier. We recently determined the transcellular wa-
ter permeability of these AQP4/5-expressing OSCs in response
to perilymphatic osmolarity shifts (osmotic water permeability
coefficient, Pf) at 156.90×10
−3 cm s−1 in the guinea pig cochlea
[21]. This high osmoticwater permeability ismore than 255-fold
that of other epithelial cells at the cochlear perilymph–endo-
lymph barrier (Pf=6.15×10
−4 cm s−1 [21]) and is comparable
to that of epithelia, which highly depend on AQP-facilitated
water transport, e.g., certain segments of the kidney tubule epi-
thelium.We proposed that under osmotically challenging condi-
tions induced in vivo [76], bulk water flow across the AQP4/5-
expressing OSCs in the cochlear apex putatively induces LEMs
in the baso-apical or apico-basal direction [21]. The AQP–water
shunt thereby potentially facilitates the rehydration or dehydra-
tion of the endolymphatic fluid compartment and contributes to
the maintenance of endolymphatic volume homeostasis.
Notably, most epithelia that accomplish AQP-facilitated flu-
id homeostasis adjust their rates of transepithelial water flow to
the prevailing physiological conditions by controlling the mem-
brane density of AQP channel proteins. Short-term regulation
of the AQP membrane density is commonly achieved via the
translocation of pre-formed AQP channel proteins that reside in
cytoplasmic membrane vesicles, preferentially in the apical
plasma membrane. Various translocation triggers in different
cell types have been described for eight of the 12 mammalian
AQP subtypes (AQP1–5 and AQP7–9) (reviewed in [16]).
Based on the previously established polarized membrane
localization of AQP4 (basolateral) and AQP5 (apical) in co-
chlear OSCs and the various membrane translocation mecha-
nisms for AQP5 that have been described in other epithelia,
we hypothesize in the present study that water flow through
the cochlear AQP–water shunt can be adapted to the prevail-
ing homeostatic requirements by regulated apical membrane
trafficking of AQP5 channel proteins in cochlear OSCs.
Therefore, we investigated whether two trigger pathways for
the membrane translocation of AQP5 that have already been
established in other epithelia (extracellular osmolarity changes
[34] and autonomic (muscarinic) activity [41]) are also present
in cochlear OSCs. In a first step, we performed immunofluo-
rescence double-labeling of AQP4 and AQP5 in the murine
cochlea during postnatal development to reveal the onset of
co-localized AQP4 and AQP5 expression in OSCs (i.e., the
formation of the perilymphatic–endolymphatic water shunt).
We then performed immunofluorescence labeling and in vitro
ligand binding assays to demonstrate the localization of mus-
carinic (M3) acetylcholine (ACh) receptors in OSCs in the
mouse (p14) cochlea. Finally, explants of the murine (p14)
cochlear duct were used to investigate in vitro the effect of
known AQP5 translocation triggers, i.e., extracellular osmo-
larity changes and autonomic (parasympathetic) activity [41],
on the subcellular localization of AQP5 in cochlear OSCs.
Materials and methods
Animals
Animal use for organ explantation was approved by the Com-
mittee for Animal Experiments of the Regional Council
(Regierungspräsidium) of Tübingen (dated February 4,
2013). The animals were maintained in an in-house animal
facility with free access to food and water under a standard
12-h light/dark cycle. NMRI mice at postnatal days (p) 0, 2, 4,
8, 10, 12, 14, 16, 32, 64, and 128 were obtained from an in-
house breeding colony. The cochleae from three mice at each
developmental time point from p0 to p128 and from 8 mice at
p14 were used to determine the immunolocalization of AQP4
and AQP5 in OSCs during postnatal development, as well as
the mRNA expression and the immunolocalization of M3R at
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p14. The cochleae from two mice at p4 and p38 were proc-
essed for Epon embedding. The cochleae from 23 mice at
p14–p16 were used for the in vitro M3R ligand binding assay
and to determine the translocation of AQP5 in OSCs after
in vitro incubation in low-osmolarity or high-osmolarity solu-
tions or with muscarinic antagonist/agonists, respectively.
Positive control tissue from the parotid glands was obtained
from the same mice from which the cochleae were removed.
Inner ear dissection
Animals at postnatal ages p0–p4 were decapitated using sharp
scissors. Older animals (p8–p128) were suffocated with carbon
dioxide (CO2) prior to decapitation. The dissection of the bony
labyrinth of the inner ear was conducted according to previous-
ly described methods [33] in HEPES-buffered Hank’s solution
(HHBSS; 5.36 mM KCl, 0.41 mM MgSO4·7H2O, 0.49 mM
MgCl2·6H2O, 141.5 mM NaCl, 9.99 mM C8H18N2O4S
(HEPES), 3.42 mM C5H10N2O3 (L-glutamine), 1.57 mM
CaCl2·2H2O, 6.31 mM D-glucose monohydrate, aqua dest.;
osmolality: 285 mOsm/L, pH: 7.32 as measured in one batch;
the pharmacy of the University Hospital of Tübingen).
In vitro perilymphatic perfusion and incubation
of cochlear explants
For in vitro perilymphatic perfusion of explanted cochleae
with HHBSS (285 mOsm/L), low-osmolarity solution
(HHBSS diluted with aqua dest., 200 mOsm/L), or high-
osmolarity solution (HHBSS supplemented with sucrose,
400 mOsm/L), the bony capsules of the cochleae were punc-
tured in the helicotrema region to create an outlet for the per-
fusion solutions; otherwise, the cochlear specimens remained
intact. Approximately, 300 μL of the respective solutions was
pre-warmed (37 °C) and slowly injected through the round
and oval windows into the scala tympani and the scala
vestibuli, respectively, using a syringe with a 30-gauge needle
(Microlance 3, BD Biosciences, San Jose, CA, USA). The
perfused cochleae were subsequently immersed in the solution
that was used for the perfusion of the respective specimen and
incubated at 37 °C for 10 min.
From the cochleae, which were utilized for in vitro incuba-
tion with M3R antagonist/agonists, the entire apical part of the
bony capsule was removed to expose the apical turn of the
cochlear duct. The specimens were immersed in pre-warmed
HHBSS supplemented with either the M3R agonist pilocarpine
hydrochloride (10 μM; Sigma-Aldrich, St. Louis, MO, USA)
only or with pilocarpine and the M3R antagonist atropine
(100 μM; Sigma-Aldrich) and incubated at 37 °C for 10 min.
Three cochleae were perfused with a hyperosmolar solution
(400 mOsm/L) supplemented with atropine (100μM) andwere
subsequently incubated for 10 min in the respective perfusion
solution. Positive control tissue from the parotid glands of the
same animals was sliced to a thickness of approximately
500 μm using a razor blade and processed in parallel.
All cochlear and parotid gland specimens were fixed after
in vitro incubation in ice-cold 4 % paraformaldehyde (4 %
PFA, Carl Roth GmbH, Karlsruhe, Germany) for 1 h. Three
cochleae (n=3) derived from three different animals were
assigned to each of the six experimental groups (Supplemen-
tary Table 1).
In vitro mapping of muscarinic M3 receptors using
a receptor-specific fluorescent ligand
For in vitro M3R ligand binding experiments, the bony co-
chlear capsule was removed in the apical region of the co-
chlea, and the spiral ligament in the apical cochlear turn was
dissected. Spiral ligament specimens were incubated at 37 °C
for 20 min with the fluorescent-labeled pirenzepine derivative
M3–633–AN (100 nM in 0.1 % dimethyl sulfoxide (DMSO),
Abcam, Cambridge, MA, USA) after 10 min of pre-
incubation in 0.1 % DMSO. According to the manufacturer’s
information, the receptor selectivity of M3–633–AN is
highest forM3R (pKD=7.97) compared with other muscarinic
receptor subtypes (M1: pKD=6.24, M5: pKD=6.29). In the
negative control experiments, the specimens were either incu-
bated for 30 min in 0.1 % DMSO or pre-incubated for 10 min
with the unlabeled M3R competitor 4-diphenylacetoxy-N-
methyl-piperidine methiodide (4-DAMP, 10 μM, Sigma-
Aldrich; M3: pKB=8.83 [26]) in 0.1 % DMSO prior to
20 min of incubation with M3–633–AN. After in vitro incu-
bation, the specimens were subsequently fixed in ice-cold 4 %
PFA for 20 min labeled with Alexa Fluor® 568 phalloidin
(dilution 1:400; Molecular Probes–Invitrogen, Carlsbad, CA,
USA) and counterstained using 4′,6-diamidino-2-phenylindol
(DAPI, Molecular Probes–Invitrogen, dilution 1:100 in PBS).
All specimens were protected from light during and after the
in vitro incubation. Whole-mount specimens from three co-
chleae (n=3) derived from three independent animals were
analyzed per experimental group (Supplementary Table 2).
Cryoembedding, Epon embedding, and sectioning
After fixation, all tissue specimens were immersed for 1 h in
phosphate-buffered saline (PBS) and subsequently decalcified
overnight in 2 mM ethylene-diamine-tetra-acetic acid
(EDTA). The specimens were embedded in Cryogel or in
Epon according to previously described standard methods
[33]. The cryosections were cut at 10 μm thickness using a
cryostat (Leica CM3050, Leica Biosystems, Wetzlar,
Germany) and were mounted on SuperFrost® Plus micro-
scope slides (Langenbrinck, Emmendingen, Germany). The
sections were cut at 10 μm thickness using a HM 355S rotary
microtome (Thermo Scientific, Walldorf, Germany) and
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mounted in Permount on microscope slides after toluidine
blue staining.
Human tissues
The use of human specimens for this study was approved by
the responsible ethics committees of the Uppsala University
Hospital (no. 99398, no. 22/9 1999, no. C254/4, and no. C45/
7 2007) and the University of Tübingen Medical Centre (no.
443/2013BO2). The human cochlea that was used in this
study was provided by H. Rask–Andersen (Uppsala,
Sweden). The specimen was obtained during an intracranial
tumor removal surgery from a patient with petroclival menin-
gioma. The removal of the inner ear was necessary for the
radical removal of the life-threatening tumor. The patient
had no history of otologic disease, and the pre-operatively
measured pure tone audiograms (PTA)were within the normal
range for the patient’s age; the cochlear specimen was there-
fore considered normal regarding its morphology and func-
tion. The human salivary gland specimen was obtained from a
surgical sample of the parotid gland that had been removed
during a tumor removal surgery at the Department of Otorhi-
nolaryngology—Head and Neck Surgery of the University of
Tübingen Medical Centre. The cochlea and the salivary gland
specimens used in this study were derived from two different
patients. The study was conducted according to the Declara-
tion of Helsinki, and informed consent of the patients was
obtained.
The processing of the human cochlea for immunohisto-
chemical studies was performed as previously described [20,
33]. The human parotid gland specimen was processed as
described for the murine salivary gland tissue.
Real-time quantitative PCR
Tissue samples were dissected/isolated and immediately
stored in RNAlater® (Applied Biosystems, Darmstadt,
Germany) for RNA isolation. Total RNA isolation and DNase
I treatment were performed using a RNAqueous® Micro Kit
(AM1931, Ambion, Austin, TX, USA), and complimentary
DNA synthesis was performed with a Transcriptor High Fi-
delity cDNA Synthesis Kit (05081955001, Roche Diagnos-
tics, Mannheim, Germany), both according to the manufac-
turer’s instructions. The transcript levels were determined
using the fluorescence-based Quant-iT™ assays with a
Qubit™ Quantitation Platform (Invitrogen). For each qPCR
amplification reaction, the template was adjusted to 5 ng of
total cDNA in a total volume of 20 μL, and the reaction was
performed using LightCycler® 480 Probes Master Mix
(04707494001, RocheDiagnostics) according to the manufac-
turer’s protocols. The probes were designed using RealTime
ready Single Assays (Roche Applied Science; Assay IDs:
Chrm3 (311010), Tbp (300314), Ubc (311816), and Actb
(300236)). Measurements were conducted in triplicates, and
a no-template blank served as the negative control. CT (thresh-
old cycle) values were determined using the LightCycler®
480 Software release 1.5.0 SP4 (Roche Diagnostics). Assay-
specific PCR efficiencies (E=10(−1/slope)) and errors (mean
squared error of the single data points fit to the regression line)
were calculated via the software using the slope of standard
curve experiments, which were conducted with mRNA from
the murine organ of Corti (p4) tissue (reference genes) and the
murine spinal cord (p14) tissue for Chrm3 (Supplementary
Figure 3). Transcription levels were normalized to the average
of two to three housekeeping genes and then to the reference
sample using the formula 2−ΔΔCT according to [60]
(Supplementary Table 3).
Immunofluorescence labeling
Immunofluorescence labeling of M3R, the water channel pro-
teins AQP4 and AQP5, E-cadherin, the inward rectifier-type
potassium channel Kir4.1 (Kir4.1), and Flottilin-2 (Flot-2)
was performed using the polyclonal antibodies anti-
muscarinic acetylcholine receptor M3 antibody raised in rab-
bit (dilution 1:100; ab87199, Abcam), anti-AQP4 antibody
raised in goat (1:100; sc-9888, Santa Cruz Biotechnology,
Heidelberg, Germany), anti-AQP5 antibody raised in rabbit
(1:200; AB3559 Merck-Millipore, Darmstadt, Germany), an-
ti-Kir4.1 antibody raised in goat (1:100; sc-23637, Santa
Cruz), anti-Flot-2 antibody raised in mouse (1: 50; sc-28320,
Santa Cruz), and a monoclonal anti-Uvomorulin/E-cadherin
antibody raised in rat (1:800; U3254, Sigma-Aldrich). The
primary antibodies were visualized with an Alexa 488-
conjugated anti-rabbit secondary antibody (dilution 1:400;
Molecular Probes–Invitrogen), an Alexa 568-conjugated an-
ti-mouse secondary antibody (dilution 1:400; Molecular
Probes–Invitrogen), an Alexa 546-conjugated anti-goat sec-
ondary antibody (dilution 1:400; Molecular Probes–
Invitrogen), or an Alexa 594-conjugated anti-rat secondary
antibody (dilution 1:400; Molecular Probes–Invitrogen), all
of which were raised in donkey. All antibodies were diluted
in PBS supplemented with 0.1 % Triton X-100 and 0.5 %
normal donkey serum (NDS). Membrane-associated filamen-
tous actin (F-actin) was labeled using Alexa Fluor® 568
phalloidin (dilution 1:400; Molecular Probes–Invitrogen).
For antigen retrieval prior to immunolabeling of M3R, the
cryosections were immersed in 10 mM sodium citrate buffer
(pH 6.0) and boiled in a steamer at 100 °C for 10 min.
Immunolabeling of Kir4.1 was performed after antigen re-
trieval in 1 % sodium dodecyl sulfate (SDS) for 10 min. Fol-
lowing the antigen retrieval procedures, the slides were
washed thoroughly in PBS and immunolabeled. For primary
antibodies directed against M3R and AQP5, preabsorption
experiments were performed by pre-incubating 0.1 μg/μL of
the antibody with 0.2 μg/μL of the respective control peptide
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for 1 h prior to the immunolabeling procedures. The cryosec-
tions were immunolabeled in a humidified chamber, and lat-
eral wall whole-mount preparations were labeled during free-
floating incubation. The cryosections were counterstained
using DAPI (Molecular Probes–Invitrogen, dilution 1:100 in
PBS). All cryosections and lateral wall preparations were
coverslipped using FluorSave™ mounting medium
(Calbiochem–Merck, Darmstadt, Germany).
Microscopic analysis
Immunolabeled whole-mount preparations and cryosections
were analyzed using an Axioplan 2 epifluorescence micro-
scope (Zeiss, Göttingen, Germany), an Axio Imager (M2 up-
right) with ApoTome.2 unit (Zeiss), or a Zeiss 510 laser-
scanning microscope (Zeiss).
Measurement of the baso-apical extent of AQP4
and AQP5 immunofluorescence in lateral wall
whole-mount specimens
The baso-apical extent of AQP4 and AQP5 immunofluores-
cence signals in the outer sulcus region was analyzed on
epifluorescence images of lateral wall whole-mount speci-
mens using the tool for curved length measurements in the
software Axiovision (V. 4.8.2.0, Zeiss). Representative confo-
cal images of AQP4 and AQP5 fluorescence signals in the
outer sulcus region were obtained in different focal planes:
at the luminal cell surface (apical membranes) and in the depth
of the spiral ligament where the OSCs’ root processes
(basolateral membranes) are located, respectively. Fluores-
cence images from both focal planes are merged together in
Fig. 1a.
Ratio of apical membrane-to-cytoplasm distribution
of AQP5 immunofluorescence in OSCs
For the semi-quantitative analysis of the AQP5 fluores-
cence signal intensity in the apical cell membrane and
the cytoplasm of cochlear OSCs, confocal images were
taken from cochlear specimens that were exposed
in vitro to different osmolarities or to M3R antagonist/
agonists. For acquisition of images that were semi-
quantitatively compared with each other, the same micro-
scope configuration and software settings (40-fold (0.8
numerical aperture) oil immersion objective, pinhole di-
ameter, detector gain, and amplifier offset) were applied.
Line profiles (white lines AB in Figs. 2 and 4) were traced
across single OSCs in the LSM 5 PASCAL software
(Zeiss) to obtain relative pixel densities for AQP5 and
phalloidin fluorescence signals (see example histograms
for a single OSC in Fig. 2c). The two x-axis positions at
the half maximum of the first peak of phalloidin fluores-
cence (y-axis values) were used to define the area of the
apical membrane of OSCs (dark gray-shaded areas in the
diagrams, Figs. 2 and 4). AQP5 fluorescence signals be-
tween the area of the apical membrane and endpoint BB^
of the line profile were considered cytoplasmic (light gray-
shaded areas in the diagrams, Figs. 2 and 4). Line profiles
from 30 OSCs (n=30) were captured per experimental
condition. Numerical data from the line profiles were an-
alyzed using Microsoft Excel 2013 (Microsoft, Redmond,
WA, USA). The x-axis dependent mean values of AQP5
and phalloidin fluorescence were determined for each ex-
perimental condition and plotted in Figs. 2d, e and 4d–g.
From these data, the mean values of AQP5 fluorescence
intensity in the apical cell membrane (mAQP5-m, mean val-
ue of AQP5 fluorescence intensity in the dark gray-shaded
diagram area) and the cytoplasm (mAQP5-c, mean value of
AQP5 fluorescence intensity in the light gray–shaded di-
agram area), as well as the standard deviations (SDAQP5-m
and SDAQP5-c) were determined. The ratios of the mean
AQP5 fluorescence intensity in the apical membrane over
the total AQP5 fluorescence intensity (apical membrane
and cytoplasm) in the cell (mAQP5-m/(mAQP5-m+mAQP5-c))










mAQP5−m þ mAQP5−c :
Statistical analysis
Values for the longitudinal extent of AQP4 and AQP5 expres-
sion are presented as the means with standard deviations (SD;
Fig. 1b), and statistical comparisons using the unpaired Stu-
dent’s t test were performed in Microsoft Excel 2013.
The qRT-PCR data were evaluated using ANOVA, and
statistical comparisons were performed using qBasePlus soft-
ware (Biogazelle) (Supplementary Table 1). Finally, the data
were calibrated to the biological reference group. Data are
presented as the means with SDs (Fig. 3b).
The ratios mAQP5-m/(mAQP5-m+mAQP5-c) from different ex-
perimental groups were compared for statistical significance
using a one-way analysis of variance (ANOVA) and the
Tukey’s honestly significant difference (HSD) post hoc test
to detect statistically significant differences between groups.
Ratios mAQP5-m/(mAQP5-m+mAQP5-c) are presented as the
means with SD (Figs. 2f and 4h).
For all statistical data presented, p values ≤0.05 were con-
sidered statistically significant.
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Results
Postnatal development of AQP4 and AQP5 expression
and subcellular localization in OSCs of the murine cochlea
The baso-apical extent of AQP4 and AQP5 expression in the
outer sulcus region was measured on whole-mount specimens
of the lateral wall from p0 to p128 NMRI mouse cochleae
(Fig. 1a, b). The length measurements of AQP4 immunofluo-
rescence labeling revealed a sudden onset of AQP4 expression
in the outer sulcus region of all cochlear turns between p8
(0 mm) and p10 (6.8±0.06 mm); thereafter, the longitudinal
extent of AQP4 expression in the outer sulcus region
remained constant into the late adult stages (p128). Notably,
in the inner sulcus region and the greater epithelial ridge
(GER), respectively, AQP4 was labeled as early as p2 (data
not shown). In contrast to AQP4, AQP5 expression was pres-
ent in the outer sulcus region along the entire length of the
lateral wall at birth (p0, 5.15±0.15 mm). This expression pat-
tern remained constant until p4 (6.51±0.07 mm) but rapidly
declined in the basal and middle cochlear turns between p8
(5.97±0.07mm) and p12 (2.64±0.13mm). A further, but only
gradual, decrease in the longitudinal AQP5 expression was
identified from p12 to p32 (1.46±0.06 mm), which resulted
in a total decline of the longitudinal extent of AQP5 expres-
sion of approximately 77.57 % between p4 and p32. Finally,
at p32, an overlapping AQP4 and AQP5 expression in the
apical cochlear turn was fully established over a distance of
1.46±0.06 mm. Notably, the developmental decline in AQP5
expression along the baso-apical axis of the cochlear duct
accompanied the baso-apical morphological maturation of
the outer sulcus region in NMRI mice (Supplementary
Figure 1).
Immunofluorescence labeling of AQP4 and AQP5 on
midmodiolar cryosections of the p14 NMRI mouse cochlea
revealed the polarized localization of AQP4 in the basolateral
membranes and AQP5 in the apical membranes of the OSCs.
Additionally, strong cytoplasmic AQP5 immunofluorescence
was detected in the OSCs (Fig. 1c–c^’). Consistent with pre-
vious reports, immunolabeling of AQP4 and AQP5 in positive
control tissues (murine kidney and salivary gland for AQP4
and AQP5, respectively) showed the polarized localization of
these AQP subtypes in the basolateral membranes of the inner
medullary collecting duct epithelium (AQP4, Supplementary
Figures 7e–7e^’) and in the apical membranes of salivary
gland acinar cells (AQP5, Supplementary Figures 6b–6b^’),
respectively.
Perilymphatic hyperosmolarity induces the membrane
translocation of AQP5 in OSCs
In cochleae from the experimental group, Bhypo-osmolarity^
bulging of Reissner’s membrane (two out of three specimens,
Supplementary Figures 2a and 2c) was observed, which sug-
gests a net inflow of water into the endolymphatic fluid space
driven by the high osmotic gradient directed into the scala
media in our in vitro experiments. The overall morphology
of the cochlear duct appeared intact in all three specimens
from this group, as evaluated using phalloidin-labeled cryo-
sections (Supplementary Figures 2a, 2c and 2e); however, all
three cochlear specimens in this experimental group showed
morphological damage of the OSCs in the apical turn. In these
OSCs, the disruption of the phalloidin fluorescence in the
region of their apical membranes (Fig. 2a–a^’ and Supple-
mentary Figures 2b–2b^’, 2d–2d^’ and 2f–2f^’) and the loss
of cellular integrity were noted, which suggests cellular dam-
age induced by hypo-osmotic cell swelling. Therefore, for this
particular experimental paradigm, the effect of perilymphatic
hypo-osmolarity on the subcellular localization of AQP4 and
AQP5 in OSCs could not be analyzed. The ratio mAQP5-m/
(mAQP5-m+mAQP5-c) and the corresponding SD we deter-
mined for the paradigm Bhyperosmolarity^ (=0.85±0.36)
was significantly higher (p≤0.01) compared with the para-
digm Bisoosmolarity^ (=0.57±0.31), which indicates an in-
crease in AQP5 fluorescence in the apical membranes of
OSCs induced by perilymphatic hyperosmolarity in vitro
(Fig. 2f). Notably, OSCs exhibited great differences of
AQP5 fluorescence intensity in their cytoplasm (weak AQP5
fluorescence in particular in their root processes) compared to
their apical membrane (brighter AQP5 fluorescence). In some
OSCs, the range of AQP5 fluorescence intensity between the
cytoplasm and the apical membrane area exceeded the dynam-
ic range of the spectral detector unit of the microscope, leading
to spots of saturated pixels in the digital images. Most of these
brightness-saturated spots were excluded from the semi-
quantitative analysis of AQP5 fluorescence intensity. Howev-
er, since these saturated spots were mostly observed in the
OSC’s apical membrane area in experimental conditions in
which the AQP5 membrane translocation was stimulated
Fig. 1 Expression of AQP4 and AQP5 in the outer sulcus cell (OSC)
region of the mouse cochlear duct during postnatal development. a
Immunofluorescence double labeling of AQP4 and AQP5 in spiral
ligament whole-mount preparations from the mouse cochlea between
postnatal days (p) 0 and p128. Representative confocal images of
fluorescence signals were obtained for specimens from the apical (first
row), middle (second row), and basal turn (third row) of the cochlea. b
Measurements of the total baso-apical length of the spiral ligament (gray
bars) and the baso-apical lengths of AQP4 (red bars), and AQP5
fluorescence (green bars) in the outer sulcus region. Length
measurements were obtained on whole-mount specimens derived from
4 to 6 cochleae per developmental age (numbers above bars). (Error bars
indicate SD, Student’s t test: *p≤0.05; **p≤0.01; ***p≤0.001; n.s. not
significant). c–c”’ Confocal images of the subcellular localization of
AQP5 (c’, white arrowheads in c”’) in the apical membranes and the
cytoplasm; AQP4 (c”, hollow arrowheads in c”’) in the basolateral
membranes of OSCs in the apical turn of the mouse (p14) cochlea (SP
spiral prominence, CC Claudius cells). Scale bars: (a), 20 μm; (c–c”’),
10 μm
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Fig. 2 Membrane translocation of AQP5 in outer sulcus cells (OSCs)
induced by perilymphatic hyperosmolarity in vitro. a–a”’ Representative
confocal images of AQP5 and phalloidin fluorescence in the spiral
ligament from a cochlea that was perilymphatically perfused and
incubated with a solution that was hypoosmolar (200 mOsm/L)
compared with the endolymph. The overall morphology of the cochlear
duct epithelium appeared normal (Supplementary Figure 2); only OSCs
in the apical turn showed signs of cellular damage, i.e., disruption of their
cytoplasm (asterisk, c”’) and apical membranes, as indicated by the
discontinuity of the phalloidin and AQP5 signals at their luminal cell
borders (white arrowhead, c”’). b, c Representative confocal images of
AQP5 and phalloidin fluorescence in the spiral ligament from a cochlea
that was perilymphatically perfused and incubated with a hyperosmolar
solution (400 mOsm/L). The inlay in (b’) shows the color-coded AQP5
fluorescence intensity (dark blue, low intensity; dark red, high intensity)
in the OSCs from (b’). Along the white line AB (b’ and b”) that crosses
the apical membrane and the cytoplasm of a single OSC, histograms of
phalloidin and AQP5 fluorescence intensities (c) were generated. The
dark gray-shaded area in the diagram indicates the apical cell
membrane, which was defined by the first peak of phalloidin
fluorescence; the light gray-shaded area indicates the cytoplasm. d
Average curves of AQP5 and phalloidin fluorescence intensities derived
from 30 measurements from the experimental group “hyperosmolarity”
(n=30). e Average curves of AQP5 and phalloidin fluorescence
intensities derived from 30 measurements from the “isoosmolarity”
experimental group (n=30). f Quantitative comparison of the mAQP5m/
(mAQP5m+mAQP5c) ratios for the “hyperosmolarity” and “isoosmolarity”
experimental groups. Error bars indicate the SD one-way ANOVA
followed by Tukey’s post hoc test: **p≤0.01; scale bars: 10 μm
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(experimental groups Bpilocarpine^ and Bhyperosmolarity^),
our analysis potentially slightly underestimated mAQP5-m/
(mAQP5-m+mAQP5-c) for these experimental paradigms. No
changes of AQP4 labeling in the basolateral membranes of
the OSCs were observed between the Bhyperosmolarity^ and
Bisoosmolarity^ groups (data not shown).
Muscarinic (M3) acetylcholine receptors are expressed
in OSCs in the murine cochlea and bind M3R-specific
ligands in vitro
The gene expression of M3R was detected in different parts of
the murine (p14) cochlea, including the spiral ligament (SL),
the stria vascularis (SV), the organ of Corti (OC), and the
auditory nerve with the spiral ganglia (AN) (Fig. 3a). Quanti-
tatively, the highest levels of M3R mRNAwere identified in
the OC and the AN (Fig. 3b). Standard curves for the probes
Chrm3 (M3R mRNA-specific probe), Tbp, Ubc, and Actb are
shown in Supplementary Figure 3. At the protein level, M3R
immunolabeling was detected in the OSCs that were attached
to the SL (Fig. 3c–c^’), in the SV (Supplementary Figures 4a–
4a^’), in the spiral ganglion (SGg) cells (Supplementary
Figures 4b–4b^’), and in the central part of the AN (Supple-
mentary Figures 4c–4c^’). Omitting the M3R primary anti-
body or pre-incubation of the primary antibody with the cor-
responding control peptide resulted in a complete absence of
Fig. 3 Gene expression,
immunolocalization, and in vitro
ligand binding of the muscarinic
(M3) acetylcholine receptor
(M3R) in outer sulcus cells
(OSCs) of the mouse (p14)
cochlea. a, b Quantitative real-
time PCR (qRT-PCR) data for the
M3R expression in tissue samples
from the mouse (p14) cochlea and
positive control tissue (SL spiral
ligament, SV stria vascularis, OC
organ of Corti, AN auditory nerve
with spiral ganglia, SG salivary
(parotid) gland, - negative
control). Error bars indicate the
SD, Student’s t test: **p≤0.01,
*p≤0.05. c–c”’ Immunolabeling
of M3R and the inward rectifier
type potassium channel Kir4.1 in
OSCs in the apical cochlear turn.
M3R fluorescence was detected
in the soma region (white
arrowheads) and root processes
(hollow arrowheads) of OSCs. d–
f”’ Spiral ligament whole-mount
specimens that were directly d–
d”’ incubated with the M3R
fluorescent ligand M3-633-AN,
incubated with M3-633-AN after
e–e”’ pre-incubation with the
M3R antagonist 4-DAMP, or f–
f”’ incubated with 0.1 % DMSO.
Vertical white lines in d”’, e”’,
and f”’ indicate the radial extent
of the stria vascularis (SV) and the
outer sulcus cells (OSC); white
arrowheads d”’, e”’ and f”’ point
to the M3-633-AN fluorescence
in the area of the d”’OSCs, which
is absent in e”’ and f”’. Scale
bars: c–c”’ 10 μm; d–f”’ 20 μm
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M3R immunolabeling in all cochlear turns and positive con-
trol (parotid gland) tissues (data not shown). To test whether
M3R ligands bind in vitro to M3Rs in OSCs, we incubated
whole-mount specimens of the murine (p14) spiral ligament
with the specific fluorescent M3R ligand M3–633–AN
(100 nM) alone or after pre-incubation with the unlabeled
M3R competitor 4-DAMP (10 μM). Microscopic analysis of
the phalloidin andDAPI-labeled specimens revealed a stripe of
M3–633–AN fluorescence beneath the stria vascularis in the
outer sulcus region (Fig. 3d–d^’). In specimens that were pre-
incubated with 4-DAMP (Fig. 3e–e^’) or that were incubated
in 0.1 % DMSO only (Fig. 3f–f^’), no M3–633–AN fluores-
cence was detected. The microscopic focal plane for the detec-
tion of M3–633–AN fluorescence in OSCs was chosen in the
depth of the spiral ligament whole-mount specimens, whereas
the focal plane to capture phalloidin and DAPI fluorescence
signals was set at the surface of the whole-mount specimens.
The binding of the fluorescent M3R ligand M3–633–AN in
the outer sulcus region and its competitive inhibition by
4-DAMP in vitro confirms the presence of M3Rs in OSCs.
Therefore, we postulated that the incubation of spiral ligament
whole-mount specimens with M3R antagonist/agonists en-
ables the stimulation or inhibition of M3Rs in OSCs in vitro.
Pilocarpine induces the membrane translocation of AQP5
in OSCs
Semi-quantitative analysis of AQP5 immunofluorescence in the
apical membrane and the cytoplasm of the OSCs from the ‘pi-
locarpine’ (Fig. 4a–a^’), ‘pilocarpine+atropine’ (Fig. 4b–b^’),
and ‘hyperosmolarity+atropine’ (Fig. 4c–c^’) experimental
groups was performed as previously described for the cochleae
that were exposed to iso- and hyperosmolar solutions. The av-
erage curves of AQP5 fluorescence intensity in the apical mem-
brane and the cytoplasm derived from 30 measurements per
experimental condition (n=30) are shown in Fig. 4d–g. A com-
parison of the mAQP5-m/(mAQP5-m+mAQP5-c) values from the
Bpilocarpine^ (= 0.86±0.33), Bpilocarpine+atropine^ (= 0.41±
0.15), Bhyperosmolarity+atropine^ (= 0.62±0.11), and
Bisoosmolarity^ (= 0.57±0.31) groups is shown in Fig. 4h. In
the OSCs from the pilocarpine group, a strong co-localization of
immunofluorescence signals for AQP5 and the lipid raft-
associated integral membrane protein Flot-2 was found in the
apical membrane region, whereas nearly no AQP5 and Flot-2
immunofluorescence signals were detected in the cytoplasm of
the OSCs (Supplementary Figures 6a–6a^’).
Representative images from parotid gland tissue slices
from the pilocarpine (Supplementary Figures 6b–6b^’) and
pilocarpine+atropine (Supplementary Figures 6c–6c^’)
groups showed strong AQP5 immunofluorescence at the api-
cal pole of acinar cells in the pilocarpine group, whereas in the
pilocarpine+atropine group, the AQP5 fluorescence signal
was less intense at the apical pole and distributed throughout
the cytoplasm. This positive control confirms the M3R-
regulated translocation of AQP5 in acinar cells in vitro, as
previously reported [41, 56].
Aquaporins 4 and 5 and muscarinic (M3) acetylcholine
receptors are expressed in OSCs in the human cochlea
Immunolabeling for AQP4, AQP5, and M3R in the human
cochlea revealed a cellular and subcellular localization pattern
in the OSCs that was identical to that in the OSCs in the mouse
cochlea. The OSCs in the apical turn of the human cochlea
showed a complementary membranous localization of AQP4
(basolateral) and AQP5 (apical) (Fig. 5a–a^’), as well as
immunolabeling for M3R (Fig. 5b–b^’). The OSCs in the
basal cochlear turn were labeled for AQP4 (Fig. 5c–c^’) and
M3R (Fig. 5d–d^’) but were devoid of AQP5 labeling. The
results from the positive control experiments for AQP5 and
M3R labeling on human salivary (parotid) gland tissue slices
are shown in Supplementary Figure 7.
Discussion
The complementary co-localization of AQP4 and AQP5
in the outer sulcus cells in the cochlear apex emerges
at the onset of hearing function
During the postnatal development of the murine (NMRI mice)
cochlea, AQP4 and AQP5 show distinct spatiotemporal ex-
pression patterns in OSCs along the baso-apical axis of the
cochlear duct. A sudden onset of AQP4 expression in OSCs at
all cochlear turns was observed between p8 and p10; in con-
trast, in the epithelial cells of the GER/inner sulcus region, the
onset of AQP4 expression was demonstrated as early as p2
(data not shown), which is consistent with the results of a
previous study in which AQP4 mRNA expression was detect-
ed in the murine (CD-1 mice) cochlea at p1 [36]. Our immu-
nohistochemical results therefore indicate a developmental
gradient for the onset of AQP4 expression along the radial
axis of the cochlear duct. At early postnatal ages (p0, p2),
the OSCs of all cochlear turns expressed AQP5 that was rap-
idly lost between p4 and p12 along the baso-apical axis and
finally became restricted to the OSCs in the most apical 1.46±
0.06 mm of the cochlear duct at p32. This longitudinal decline
in AQP5 expression was accompanied by the relatively late
morphological maturation of the outer sulcus, i.e., the over-
growth of OSCs by CCs in the basal and middle cochlear
turns. Similar spatiotemporal changes in the outer sulcus with
a decrease in the longitudinal extent of AQP5 expression of
65.11 % and overgrowth of OSCs by CCs were previously
described in the rat (Wistar rats) cochlea [8, 33]. These spa-
tiotemporal changes in AQP4 and AQP5 expression in OSCs
in the mouse (Fig. 6a) and rat (Fig. 6b, data from [33])
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Fig. 4 Membrane translocation of AQP5 in outer sulcus cells (OSCs)
in vitro is controlled by muscarinic (M3) acetylcholine receptors. a–c”’
Representative confocal images of AQP5 and phalloidin fluorescence in
the spiral ligament of the apical turn of cochlear specimens from the
“pilocarpine” (a–a”’), “pilocarpine + atropine” (b–b”’), and
“hyperosmolarity+atropine” (c–c”’) experimental groups. Inlays in (a’),
(b’), and (c’) show the color-coded AQP5 fluorescence intensity (dark
blue low intensity; dark red high intensity) in OSCs. White lines AB in
(a’), (a”), (b’), (b”), (c’), and (c”) were used to generate histograms of
phalloidin and AQP5 fluorescence intensities for single OSCs. d–g
Average curves of AQP5 and phalloidin fluorescence intensities derived
from 30 measurements (n=30) from the pilocarpine, pilocarpine+
atropine, hyperosmolarity+atropine, and isoosmolarity experimental
groups. The dark gray-shaded area in the diagrams indicates the apical
cell membrane, which was defined using the first peak of phalloidin
fluorescence; the light gray-shaded area indicates the cytoplasm. h
Quantitative comparison of the mAQP5m/(mAQP5m+mAQP5c) ratios that
were calculated based on the data shown in d–g. Relative fluorescence
intensity (rel. FI) in d–g is shown in arbitrary units (aU). Error bars
indicate the SD, one-way ANOVA followed by Tukey’s post hoc test:
n.s. no statistical significance; *p≤0.05; **p≤0.01; ***p≤0.001;
****p≤0.0001. Scale bars: 10 μm
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cochleae converge in the formation of a perilymphatic–endo-
lymphatic Bwater shunt^ in the cochlear apex [19, 21, 33] and
parallel the functional maturation of the hearing organ, i.e., an
increase in the endocochlear potential (EP) and a reduction in
compound action potential (CAP) thresholds [7, 64].
The longitudinal extent of the overlapping membrane ex-
pression of AQP4 (basolateral) and AQP5 (apical) at an adult-
like age (p128) represented 22.32 % of the total length of the
murine (NMRI) cochlear duct, which is consistent with the
previously measured extent of AQP5 expression in the rat
(Wistar rats; p128) cochlear duct (29.1 % of the total length
[33]) but considerably longer compared with the extent of
overlapping AQP4/AQP5 expression in the adult guinea pig
(strain BFA bunt) cochlear duct (3.97 % of the total length
[21]). These marked differences in the surface area of the
AQP4/AQP5–water shunt in the cochlear apex between ro-
dent species potentially reflect different physiological require-
ments for water homeostasis in the cochlea. Such species-
specific differences have already been proposed based on re-
sults from in vivo experiments in which the endolymphatic
duct and sac (portions of the inner ear epithelium that presum-
ably act in inner ear fluid regulation) had been surgically
destroyed [52, 61]; guinea pigs reliably developed an
overaccumulation of endolymphatic fluid (i.e., endolymphatic
hydrops) within days to weeks after surgery, whereas rats were
much less susceptible to this ablative treatment and developed
an endolymphatic hydrops in only about half of the cases.
Disturbances in perilymphatic osmolarity induce
the apical membrane translocation of AQP5 water
channels and challenge cell survival in outer sulcus cells
in the cochlear apex
In the present study, an in vitro induced increase in the
perilymphatic osmolarity to 400 mOsm/L for 10 min resulted
in a significant increase in AQP5 immunofluorescence in the
apical membrane of OSCs and a reduced AQP5 fluorescence
in the cytoplasm, which suggests a tonicity-induced membrane
translocation of AQP5 water channels. Furthermore, an in vitro
decrease in the perilymphatic osmolarity to 200 mOsm/L for
10 min resulted in a selective cellular damage of AQP4/AQP5-
expressing OSCs in the cochlear apex with morphologically
determined loss of their apical membrane barrier.
Changes in extracellular osmolarity are an established trig-
ger for the regulation of AQP membrane abundance. In dif-
ferent in vitro and in vivo models, hypo-osmolarity induced
the membrane translocation of AQP1, AQP3, and AQP8,
whereas hyperosmolarity induced the membrane translocation
of AQP1–5 and AQP9 [reviewed in 16]. The regulation of
AQPmembrane abundance by osmotic gradients enables cells
to rapidly and selectively adjust the water concentration in
their cytosols and the surrounding extracellular compartments
to the prevailing physiological requirements.
In the cochlea, differences in the ionic concentrations [77]
and osmolarities are present between the endolymphatic
Fig. 5 Immunolocalization of
AQP4, AQP5, and M3R in outer
sulcus cells (OSCs) of the adult
human cochlea. a–b”’ In the
apical turn, AQP4 labeling was
localized in the basolateral
membranes (hollow arrowheads,
a”’), and AQP5 labeling was
detected in the apical membranes
and the subapical cytoplasm
(white arrowheads, a”’) of OSCs.
M3R labeling was also detected
in OSCs in the apical cochlear
turn (b’–b”’). c–d”’ In the basal
turn, OSCs exhibited AQP4
labeling in their basolateral
membranes (hollow arrowheads,
c”’) but were devoid of AQP5
labeling. OSCs in the basal
cochlear turn were also
immunoreactive for M3R (d–d”’)
(White arrows in (a”’ and c”’)
indicate AQP4 labeling in the
basal membranes of Claudius
cells (CCs) in the apical (A”’) and
basal turn (C”’)). (SP spiral
prominence). Scale bars: 20 μm
2582 Pflugers Arch - Eur J Physiol (2015) 467:2571–2588
(322.7 mOsm/L (mean of all cochlear turns)) and
perilymphatic fluid compartments (298 mOsm/L) [79]. These
ionic and osmotic gradients are maintained by molecular ion
transport mechanisms [reviewed in 55] and the tight membra-
nous boundaries that seal the endolymphatic fluid space, des-
ignated the Bperilymph–endolymph barrier^ [28, 44], both of
which are established by cells of the cochlear duct. The dis-
tinct ionic and osmotic concentrations in the cochlear fluids
are continuously challenged by transepithelial ion movements
across the cochlear duct epithelium, as well as serum osmo-
larity changes that are rapidly transferred to the perilymphatic
fluid via the relatively permeable blood–perilymph barrier
[47, 48, 80]. In humans, serum osmolarities between 241
and 352 mOsm/L have been reported [71]. Changes in peri-
lymph osmolarities within the same range were demonstrated
to affect cochlear function in guinea pigs in vivo (260 and
340 mOsm/L, respectively) [15] and cause transiently in-
creased thresholds of stimulus-related cochlear potentials, spe-
cifically at low frequencies (262 mOsm/L [46]). Salt and
DeMott [76] demonstrated in vivo that osmolarity changes
in the perilymphatic fluid induce LEMs, which in turn account
for the correction of osmolarity-induced endolymphatic vol-
ume disturbances. In a recent study in which we investigated
the molecular basis of LEMs in the cochlea, we determined a
remarkably high osmotic water permeability (osmotic water
permeability coefficient (Pf) of 156.90×10
−3 cm/s) for OSCs
in the cochlear apex during perilymphatic hyperosmolarity;
we proposed a model explaining LEMs based on osmotically
driven water flow through AQP4 and AQP5 in these OSCs
[21]. The results of the present study support this model by
Fig. 6 a, b In the postnatal development of the mouse (a) and the rat
cochlea (b), the baso-apical decline of AQP5 expression in OSCs (green
curves) and the onset of AQP4 expression (red curve in a, red dots in b)
temporally coincide with the formation of the endocochlear potential (EP,
black dashed lines) and the lowering of the compound action potential
(CAP) thresholds (black dotted lines) around p10. CAP thresholds are
provided for the 5-kHz frequency. EP and CAP data in a and b were
reprinted from [7] and [64] with the kind permission of the publishers of
Informa Healthcare and Elsevier); asterisk data point is based on our
unpublished data. c–e Schematic illustration of AQP5 apical membrane
translocation in OSCs (orange cells) in response to perilymphatic
hyperosmolarity (c), muscarinic (M3R) agonism (d), and its
internalization into the cytoplasm induced by muscarinic (M3R)
antagonism (e). The cellular signaling cascade by which extracellular
osmolarity changes induce AQP5 membrane translocation remain
unknown (? in c). The source of physiological M3R agonists that
stimulate AQP5 membrane translocation in OSCs could be the blood
plasma [considering the dense vascularization of the spiral ligament ((1)
in d)) or cells of the cochlear duct ((2) in (d)), which are a source for non-
neuronal acetylcholine (ACh) that would act on M3Rs in OSCs in a
paracrine manner. Direct M3R antagonism (e) blocks the membrane
translocation of AQP5 water channels in OSCs. Therefore, the reduced
water permeability of the apical membrane domain restricts transcellular
water movements across OSCs. Note that AQP4 constitutively facilitates
water movements across the basolateral membrane domain of OSCs (c–e).
Black arrows indicate the directions of putative transcellular water flow
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indicating that perilymphatic hyperosmolarity increases the
membrane abundance of AQP5 in OSCs and thereby poten-
tially facilitates water movements from the endolymphatic to
the perilymphatic fluid compartment along the prevailing os-
motic gradient (Fig. 6c).
In contrast, perilymphatic hypoosmolarity (200 mOsm/L,
10 min) in vitro resulted in histologically discernable endo-
lymphatic hydrops (in two out of three specimens), which
suggests a net water flow into the endolymphatic fluid space
across the perilymph–endolymph barrier. According to our
previous model [21], perilymphatic hypo-osmolarity forces
water to flow across AQP4/AQP5-expressing OSCs in the
cochlear apex into the endolymphatic fluid space, which re-
sults in apico-basally-directed LEMs. In our experiments, a
reduction in perilymphatic osmolarity to 200 mOsm/L caused
histologically determined cell damage that was restricted to
AQP4/AQP5-expressing OSCs in the cochlear apex (in three
out of three specimens). This finding may be explained by the
constitutively high osmotic water permeability of the large,
AQP4-expressing basolateral membranes of OSCs, which in
our experiments enabled excess cellular water entry and con-
secutive osmotic cytolysis. Morphologically, the hypo-
osmolarity-induced disruption of OSCs was consistent with
a local breakdown of the perilymph-endolymph barrier in
the cochlear apex. This loss of barrier function in OSCs might
account for the incomplete recovery of the EP and the endo-
lymph volume after perilymphatic perfusion with hypo-
osmolar (relative to the endolymph osmolarity) solution, as
observed by Salt and DeMott [76].
In conclusion, we show in the present study that AQP5 in
AQP4/AQP5-expressing OSCs in the cochlear apex is dy-
namically regulated by changes in perilymphatic osmolarity.
The hyperosmolarity-induced membrane translocation of
AQP5 presumably raises their transcellular water permeability
and enables OSCs to mediate osmotically driven water move-
ments that induce LEMs and are crucial for cochlear fluid
homeostasis.
Autonomic (muscarinic) activation induces the apical
membrane translocation of AQP5 water channels in outer
sulcus cells in the cochlear apex
In the present study, M3R mRNA expression in the lateral
wall, M3R immunolocalization inOSCs, and in vitro mapping
of M3R with a receptor-specific fluorescent ligand confirmed
the presence of M3Rs in AQP4/AQP5-expressing OSCs. The
in vitro application of the M3R agonist pilocarpine (10 μM)
significantly increased AQP5 immunofluorescence in the api-
cal membranes of OSCs, whereas this effect was blocked by
the simultaneous application of the M3R antagonist atropine
(100 μM). Additionally, after pilocarpine treatment, a strong
membrane colocalization of immunofluorescence signals for
AQP5 and flotillin-2—a marker for specialized membrane
domains that are involved in vesicular trafficking—in OSCs
suggests the pilocarpine-induced fusion of AQP5-containing
intracellular membrane vesicles with the apical cell mem-
brane. These results indicate a M3R-mediated membrane
translocation mechanism in AQP4/AQP5-expressing OSCs
in the cochlear apex.
An M3R-mediated apical membrane translocation of the
AQP5 water channel has been shown or discussed for several
AQP5-expressing secretory tissues, including salivary [24, 25,
41, 42, 56], lacrimal [39], and sweat glands [38, 68, 78], as well
as the lung alveolar epithelium (proven cAMP-dependent
translocation cascade [88, 89]). In these tissues, autonomic
(muscarinic) stimuli increase the AQP5-mediated
transepithelial fluid flow via M3R activation and thereby in-
crease the secretion rate for saliva, tear fluid, sweat, and mucus.
In the cochlea, endolymphatic K+ secretion by the stria
vascularis, which is required for the maintenance of the EP
and a constant volume of endolymph, is stimulated by β1
adrenergic agonists and inhibited byM3 and/or M4 muscarin-
ic agonists [86, 87]. This finding suggests an autonomic reg-
ulation of endolymph production in the cochlea. Based on the
present study, we propose to extend the muscarinic regulation
of AQP5 mediated water flow to the OSCs (Fig. 6d, e). Inter-
estingly, OSCs were previously established as a parasensory
pathway for the resorption of cations from endolymph (K+,
Na+) based on their apical membrane expression of potassium
channels (BK channels) and chloride/iodide transporters
(pendrin) [13, 14, 43, 57, 62]. This finding suggests that cho-
linergic (muscarinic) stimuli in the cochlea can downregulate
the endolymph production by the stria vascularis and simulta-
neously upregulate the water permeability of the OSCs. More-
over, muscarinic stimuli may also regulate the activity of ion
channels and transporters in OSCs in order to control
parasensory ion reabsorption from the endolymphatic fluid.
Taken together, the concerted muscarinic effects on stria
vascularis cells and OSCs are presumably of significance for
the maintenance of a constant endolymph volume.
Moreover, in the present study, we demonstrated that AQP5
membrane translocation in OSCs induced by the perilymphatic
application of a hyperosmolar solution was partially blocked by
atropine. It remains unclear how M3R antagonism interferes
with the cellular signaling cascade that mediates perilymphatic
hyperosmolarity-induced AQP5 membrane translocation in
OSCs; however, other examples of the inhibition of
hyperosmolarity-induced cellular effects by blocking G-
protein coupled receptors (GPCRs) or targets in their respective
intracellular signaling cascade (e.g., the blockade of neurokinin
3 receptors (NK3R) in the paraventricular nucleus of the hypo-
thalamus inhibits the hyperosmolarity-induced release of vaso-
pressin [29]), and the blockade of phosphokinase A (PKA)
inhibits the vasopressin-2 receptor (V2R)-mediated apical
membrane translocation of AQP2 in cultured renal-collecting
duct principal cells [30].
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In conclusion, in the present study, we provide evidence for
the dynamic regulation of AQP5 localization in AQP4/AQP5-
expressing OSCs by muscarinic agonists/antagonists via
M3R. The M3R-controlled AQP5 membrane translocation
in OSCs in the cochlear apex presumably regulates their trans-
cellular water permeability and constitutes a regulatory mech-
anism for the perilymphatic–endolymphatic water homeosta-
sis by autonomic stimuli.
Potential implications for the regulated aquaporin-based
water shunt in endolymphatic hydrops and Ménière’s
disease
In the present study, we demonstrated that the molecular de-
terminants of the regulated AQP-based water shunt (AQP4,
AQP5, and M3R) are also expressed in OSCs in the apex of
the human cochlea. Therefore, failure in the human cochlear
AQP4/AQP5–water shunt could contribute to impaired endo-
lymph volume homeostasis, e.g., leading to the endolymphat-
ic hydrops in Ménière’s disease.
In Ménière’s disease, the generation of endolymphatic
hydrops has been attributed to osmotic imbalances between
the cochlear fluid compartments [54] and to the stagnation of
LEMs that putatively counteract these imbalances [27, 76].
We have shown that the perilymphatic osmolarity changes
that induce LEMs in vivo [76] regulate the membrane abun-
dance of AQP5 water channels in OSCs in the cochlear apex.
The dysregulation of this AQP-based water shunt may poten-
tially impair LEMs and thereby contribute to the generation of
the endolymphatic hydrops in Ménière’s disease. This dysreg-
ulation could manifest in two ways: (i) the perilymphatic–
endolymphatic osmotic gradient, which constitutes the driving
force for transcellular water movements across the
AQP4/AQP5–water shunt, is disturbed and/or (ii) the AQP-
based transcellular water permeability of the AQP4/AQP5–
water shunt is altered. In line with (i), altered serum osmolar-
ities have been reported in Ménière’s patients in acute attacks
and during remission phases [5, 11, 12, 50, 53, 81]. Moreover,
in the clinical diagnosis of Ménière’s disease, the sugar alco-
hol glycerol is administered orally or intravenously to increase
the serum and perilymph osmolarity and thereby osmotically
drain the hydropic endolymphatic fluid space and temporarily
improve audiometric hearing thresholds (in the early disease
state when endolymphatic hydrops remains reversible) [54].
This finding implies that endolymphatic hydrops in Ménière’s
disease is a consequence of osmotic imbalances that can be
temporally compensated by osmotically forced (induction of
perilymphatic hyperosmolarity) water outflow from the endo-
lymph across the boundaries of the cochlear duct epithelium,
as demonstrated in vivo [17, 18, 49, 65, 82]. In line with (i)
and (ii), the serum (and perilymph) osmolarity [9] and the
AQP5 membrane abundance in OSCs (present study) are both
control led by the autonomic system. Autonomic
dysregulation has been proposed as a contributing factor to
Ménière’s disease based on elevated serum levels of stress
hormones [6, 35, 70, 85] and hyperreactivity of peripheral
cholinergic receptors [63], as well as abnormal pupillary re-
flexes in response to muscarinic stimulation (methacholine
test) [37, 83, 84] and sympathetic hypofunction [90]
homolateral to the diseased inner ear in Ménière’s patients.
Therefore, autonomic dysregulation in Ménière’s disease
could not only account for pathological serum (and peri-
lymph) osmolarity changes but also alter the cholinergic
(M3R)-controlled AQP5 membrane abundance in OSCs that
presumably determines its high transcellular water permeabil-
ity ([21], present study). Finally, in line with (ii), several nat-
urally occurring AQP5 single nucleotide polymorphisms
(SNPs)/mutations have been reported to affect the membrane
targeting of AQP5 water channel proteins [66] and the tran-
scription rate of the AQP5 gene [1] or to render AQP5 water
channels leaky and/or more sensitive to hypotonicity [10].
These AQP5 gene SNPs/mutations are of potential clinical
significance because they are associated with decreased saliva
secretion (in rats [66]), altered responses of the renin–angio-
tensin–aldosterone system (RAAS) to salt loading [1], and the
occurrence of palmoplantar keratoderma Bothnia type in
humans [10]. Interestingly, another AQP5 SNP (variant G
allele of rs3736309) was recently associated with a reduced
risk for Ménière’s disease [69]; however, the impact of this
SNP on the single channel–water permeability and membrane
trafficking of the AQP5 channel proteins is unknown. It is also
not known whether the abovementioned pathologies/
mutations affect the membrane trafficking and/or water per-
meability of AQP5 channels in cochlear OSCs. AQP5-
deficient mice do not exhibit an auditory phenotype (based
on auditory brainstem response (ABR) measurements) [59],
which suggests that at least under normal conditions other
mechanisms may compensate for AQP5 function in the co-
chlea and thereby maintain endolymphatic fluid homeostasis.
In contrast, AQP4-deficient mice show a severe sensorineural
hearing loss [59]; however, this cannot be attributed to a dys-
function of the AQP4/AQP5-water shunt in cochlear OSCs,
since AQP4 is also abundantly expressed in many other
supporting cell types of the cochlear duct [20, 32]. To eluci-
date the physiological role and pathologic implications of the
cochlear AQP–water shunt in endolymphatic volume homeo-
stasis, further studies using in vivo approaches are required.
In conclusion, disturbances in the osmotic driving forces
for water movements across the AQP4/AQP5–water shunt
and the dysregulation of AQP5-based water permeability
may both originate from the autonomic dysregulation that is
associated with Ménière’s disease and contributes to the gen-
eration of endolymphatic hydrops.
In summary, we provide morphological evidence for a mo-
lecular water shunt based on the membrane localization of
AQP4 (basolateral) and AQP5 (apical) in OSCs in the murine
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cochlear apex that develops at the onset of hearing function.
The abundance of AQP5 water channels was increased
in vitro by perilymphatic hyperosmolarity and muscarinic
(M3) receptor stimulation in OSCs, which indicates the regu-
lation of transcellular water permeability in the OSCs by os-
molarity changes in the cochlear fluids and autonomic stimuli.
We also revealed the molecular determinants of this regulated
water shunt to be expressed in OSCs in the apex of the human
cochlea. We postulated a potential function of this regulated
water shunt in endolymph volume homeostasis and speculated
about an affection of its regulated water permeability in
Ménière’s disease.
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